|
Volumn 119, Issue 3, 2013, Pages 472-473
|
Aspirin extends life of some patients with colorectal cancer.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
NONSTEROID ANTIINFLAMMATORY AGENT;
PHOSPHATIDYLINOSITOL 3 KINASE;
PIK3CA PROTEIN, HUMAN;
CARCINOMA;
CLINICAL TRIAL (TOPIC);
COLORECTAL TUMOR;
DRUG EFFECT;
FOLLOW UP;
GENETICS;
HUMAN;
LONGEVITY;
MORTALITY;
MUTATION;
NOTE;
PHYSIOLOGY;
SURVIVAL RATE;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ASPIRIN;
CARCINOMA;
CLINICAL TRIALS AS TOPIC;
COLORECTAL NEOPLASMS;
FOLLOW-UP STUDIES;
HUMANS;
LONGEVITY;
MUTATION;
PHOSPHATIDYLINOSITOL 3-KINASES;
SURVIVAL RATE;
|
EID: 84875269490
PISSN: None
EISSN: 10970142
Source Type: Journal
DOI: 10.1002/cncr.27961 Document Type: Note |
Times cited : (4)
|
References (0)
|